Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study

NCT05175469 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05175469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05175469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2022
Completion date
January 31, 2025
Enrollment
400 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes